Predictmedix AI Inc. (CSE: PMED, OTC: PMEDF, FRA: 3QP0), a rising leader in AI-driven health and safety technology, will present at the 25th MK Investment Conference on October 1, 2025. The event, hosted by Michael Kott and CM-Equity AG, attracts a broad investor audience focused on AI, longevity, tech, and ESG sectors, making it a prime platform for emerging innovators.
AI Meets Health and Safety
Dr. Rahul Kushwah, COO and Co-founder of Predictmedix, will lead the company’s presentation, showcasing AI technologies designed to enhance health management, clinical trials, and screening. By leveraging AI for efficiency, scalability, and accessibility, Predictmedix aims to transform the way healthcare and workplace safety are monitored and managed.
“AI is the major tech theme today. AI touches all lives, and our technology is built with that self-evident intent,” said Dr. Kushwah. “Predictmedix is positioned at the heart of the AI revolution—delivering real-world solutions with meaningful impact in healthcare and beyond.”
Investor Spotlight
The MK Investment Conference serves as a gateway to exclusive investment opportunities, featuring innovative private companies and upcoming IPOs. With global interest in AI at unprecedented levels, Predictmedix is poised to engage with investors seeking high-growth, technology-driven healthcare solutions. The company plans to highlight key milestones, growth strategies, and its vision for scaling AI-powered health and safety applications worldwide.
By presenting in Munich, Predictmedix signals its ambition to expand visibility in European capital markets and reinforce its role as a leader in AI health technology.
Power Tomorrow’s Intelligence — Build It with TechEdgeAI
